External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home AAO 2021
Roche and Genentech at

AAO 2021

November 12 - November 15
New Orleans / Virtual (Hybrid)
aao.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:38 AM
Duration 6mins New Orleans, LA
Interim Analysis Results of the Phase 3 Portal Trial Evaluating the Long-Term Safety and Efficacy of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular Age-related Macular Degeneration (nAMD)
Campochiaro P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:44 AM
Duration 6mins New Orleans, LA
Faricimab In Neovascular Age-related Macular Degeneration: 1-year Efficacy, Safety, and Durability in the Phase 3 TENAYA and LUCERNE Trials
Regillo C
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:30 AM
Duration 6mins New Orleans, LA
Phase 3 YOSEMITE and RHINE study results
Heier J
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:00 PM
Duration 7mins New Orleans, LA
Efficacy and Safety of Faricimab in Diabetic Macular Edema: One-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Ferrone P, Wykoff C, Tadayoni R, Haskova Z, Silverman D, Ives J, Basu K, Lin H
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:00 PM
Duration 7mins New Orleans, LA
Faricimab in Neovascular Age-related Macular Degeneration: Primary Results From the Phase 3 TENAYA and LUCERNE Trials
Singh R, Heier J, Holz F, Quezada-Ruiz C, Silverman D, Ives J, Basu K, Lin H
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:54 AM
Duration 7mins New Orleans, LA
The Port Delivery System With Ranibizumab (PDS): A New Paradigm for Long-Acting Retinal Drug Delivery
Stewart J, Wieland M, Tam T, Horvath J, Rea J, Barteselli G, Ranade S
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.